[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367385-105":59,"doc-detail-367385-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","low-coverage-whole-genome-sequencing-of-lowgrade-dysplasia-strongly-predicts-advanced-neoplasia-risk-in-ulcerative-colitis-original-research","Low-coverage whole genome sequencing of lowgrade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis - Original research","","Background: The risk of advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with low-grade dysplasia (LGD) is variable and difficult to predict, complicating clinical management. Objective: To stratify AN risk in UC-LGD by testing whether somatic genomic copy number alterations (CNAs) in LGD lesions forecast future AN. Design: Retrospective multicentre validated case-control study (n=270 LGD samples, n=122 patients) with baseline sequencing, CNA detection, and survival analysis. Results: CNA burden was higher in progressors and strongly predicted AN risk, outperforming clinical factors; multivariate prediction combined CNA burden with incomplete LGD resection. Conclusion: CNA measurement in LGD is an accurate predictor supporting improved management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/low-coverage-whole-genome-sequencing-of-lowgrade-dysplasia-strongly-predicts-advanced-neoplasia-risk-in-ulcerative-colitis-original-research/367385/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/low-coverage-whole-genome-sequencing-of-lowgrade-dysplasia-strongly-predicts-advanced-neoplasia-risk-in-ulcerative-colitis-original-research/367385.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does this study address in ulcerative colitis patients with low-grade dysplasia?","Question",{"text":112,"@type":113},"The study targets the variable and difficult-to-predict risk of advanced neoplasia in UC patients who have low-grade dysplasia, which makes clinical monitoring and treatment decisions uncertain.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was advanced neoplasia risk assessed in the study design?",{"text":117,"@type":113},"Researchers performed a retrospective multicentre validated case-control study using baseline LGD samples, conducted low-coverage whole genome sequencing, detected somatic copy number alterations, and used survival analysis to evaluate predictors.",{"name":119,"@type":110,"acceptedAnswer":120},"What predicts advanced neoplasia risk according to the results?",{"text":121,"@type":113},"CNA burden in resected LGD lesions was significantly higher in progressors and strongly predicted future advanced neoplasia risk, outperforming existing clinical risk factors, especially when combined with incomplete LGD resection in a multivariate model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367385,1790377024,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Inflammatory bowel disease  \nOriginal research  \nLow-coverage whole genome sequencing of lowgrade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis  \nIbrahim Al Bakir, 1,2,3 Kit Curtius, 1,4,5,6 George D Cresswell  ,7,8 Heather E Grant,7 Nadia Nasreddin,9 Kane Smith, 1,7 Salpie Nowinski, 1,7 Qingli Guo, 1,7  \nHayley L Belnoue-Davis,9 Jennifer Fisher,2,7 Theo Clarke, 1 Christopher Kimberley, 1 Maximilian Mossner, 1,7 Philip D Dunne  , 10 Maurice B Loughrey  , 11,12  \nAlly Speight, 13 James E East  , 14 Nicholas A Wright, 1 Manuel Rodriguez-Justo,15,16 Marnix Jansen, 15,16 Morgan Moorghen, 17 Ann-Marie Baker,1,7 Simon J Leedham,9,14 Ailsa L Hart,2,18 Trevor A Graham  1,7  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1136/gutjnl-2024-333353](10.1136/gutjnl-2024-333353)) .  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Kit Curtius; [kcurtius@health.ucsd.edu](kcurtius@health.ucsd.edu)[ ](kcurtius@health.ucsd.edu)Professor Simon J Leedham; [simon.leedham@well.ox.ac.uk](simon.leedham@well.ox.ac.uk); Professor Ailsa L Hart; ailsa. [hart@nhs.net](hart@nhs.net) and Professor Trevor A Graham; [trevor.graham@icr.ac.uk](trevor.graham@icr.ac.uk)  \nIAB and KC are joint first authors.  \nSJL, ALH and TAG are joint senior authors.  \nReceived 12 July 2024  \nAccepted 19 December 2024  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nTo cite: Al Bakir I, Curtius K, Cresswell GD, et al. Gut Epub ahead of print: [please include Day Month Year] . doi:10.1136/ gutjnl-2024-333353  \nABSTRACT  \nBackground The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and difficult to predict. This is a major challenge for effective clinical management. Objective We aimed to provide accurate AN risk stratification in UC patients with LGD. We hypothesised that the pattern and burden of somatic genomic copy number alterations (CNAs) in LGD lesions could predict future AN risk.  \nDesign We performed a retrospective multicentre validated case–control study using n=270 LGD samples from n=122 patients with UC. Patients were designated progressors (n=40) if they had a diagnosis of AN in the~5 years following LGD diagnosis or non-progressors (n=82) if they remained AN-free during follow-up. DNA was extracted from the baseline LGD lesion, lowcoverage whole genome sequencing performed and data processed to detect CNAs. Survival analysis was used to evaluate CNAs as predictors of future AN risk.  \nResults CNA burden was significantly higher in progressors than non-progressors (p=2×10−6 in discovery cohort) and was a very significant predictor of AN risk in univariate analysis (OR=36; p=9×10−7), outperforming existing clinical risk factors such as lesion size, shape and focality. Optimal risk prediction was achieved with a multivariate model combining CNA burden with the known clinical risk factor of incomplete LGD resection. Within-LGD lesion genetic heterogeneity did not confound risk prediction.  \nConclusion Measurement of CNAs in LGD is an accurate predictor of AN risk in inflammatory bowel disease and is likely to support clinical management.  \nINTRODUCTION  \nThe management of colitis-associated colorectal cancer (CA-CRC) risk suffers from both chronic underdiagnosis and overdiagnosis, leading to uncertainty in how to best monitor and treat patients. Patients with colitis are offered enrolment into  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Patients with ulcerative colitis (UC) are at increased risk of colorectal cancer (CRC), and this risk increases dramatically in those who develop low-grade dysplasia (LGD) . However, there is currently no accurate way to riskstratify UC pat","cbCaiu5oJWIRfhQ7","https://ap.wps.com/l/cbCaiu5oJWIRfhQ7","pdf",4041796,12,"English","# Abstract\n## Background and objective\n## Design and methods\n## Results\n## Conclusion\n# Introduction\n## Clinical challenge and need for risk stratification\n# What is already known on this topic\n## Existing risk and monitoring limitations\n# What this study adds\n## Main findings on CNAs and prediction","[{\"question\":\"What problem does this study address in ulcerative colitis patients with low-grade dysplasia?\",\"answer\":\"The study targets the variable and difficult-to-predict risk of advanced neoplasia in UC patients who have low-grade dysplasia, which makes clinical monitoring and treatment decisions uncertain.\"},{\"question\":\"How was advanced neoplasia risk assessed in the study design?\",\"answer\":\"Researchers performed a retrospective multicentre validated case-control study using baseline LGD samples, conducted low-coverage whole genome sequencing, detected somatic copy number alterations, and used survival analysis to evaluate predictors.\"},{\"question\":\"What predicts advanced neoplasia risk according to the results?\",\"answer\":\"CNA burden in resected LGD lesions was significantly higher in progressors and strongly predicted future advanced neoplasia risk, outperforming existing clinical risk factors, especially when combined with incomplete LGD resection in a multivariate model.\"}]","Low-coverage whole genome sequencing of lowgrade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis - Original research | PDF",1790170569,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ca8e844adce248a70adc45f7ffa24bb.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a433d95abafef9291b926b759648e8ce.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec9e6609f8b9a4df76aaea7e46f29f4d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/785c5a1d320cf7d92c9a2ffe1a87556d.webp",980,1306]